Afficher les filtres
Type de ressources
Filtrer par Type de ressources
Filtrer par Pathologies
Filtrer par Technologies
Filtrer par Instruments
66 Résultat(s) trouvé(s)
Trié par:

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Communiqué de presse
Dec. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

Dec. 09, 2023 Dec. 11, 2023

San Diego, CA

ASH 2023

Sebia booth: #2455

En savoir plus

Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum

Aug. 31, 2023

Educational Webinar with Dr. Matthias Orth from University of Heidelberg at University Hospital Mannheim.

Improving the diagnosis of AATD with aid of Serum Protein Electrophoresis

Aug. 23, 2023

Educational Workshop with Dr. Ilaria Ferrarotti

Sep. 27, 2023 Sep. 30, 2023

Athens, Greece

IMS 2023

Sebia booth: #211

En savoir plus

Aug. 27, 2023 Aug. 31, 2023

Roma, Italy

TIAFT 2023

Sebia booth: #8

En savoir plus

Clinical use of FLC testing in Multiple Myeloma and AL Amyloidosis

Jun. 15, 2023

Educational Workshop with Pr Giovanni Palladini

Methods for FLC quantification

Jun. 13, 2023

Educational Workshop with Dr Matthias Orth